- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neurogenic Bladder in South Africa
Total 251 results
-
Boehringer IngelheimCompletedBladder, NeurogenicBelgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
-
Boehringer IngelheimCompletedBladder, NeurogenicBelgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
-
BayerCompletedOveractive BladderSouth Africa
-
PfizerCompletedUrinary Bladder, NeurogenicFrance, United States, Spain, Korea, Republic of, United Kingdom, Malaysia, Taiwan, Finland, Japan, Lithuania, Italy, Turkey, Estonia, Slovakia, Belgium, Canada, Germany, Greece, India, Philippines, Poland, Russian Federation, South... and more
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
Hellenic GenitoUrinary Cancer GroupActive, not recruiting
-
Hellenic GenitoUrinary Cancer GroupRecruiting
-
National and Kapodistrian University of AthensCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedIdiopathic Overactive BladderUnited Kingdom
-
Asieris Pharmaceuticals (AUS) Pty Ltd.Completed
-
Asieris Pharmaceutical Technologies Co., Ltd.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
Medical University of South CarolinaTerminatedBladder CancerUnited States
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
Medical University of South CarolinaCompletedCough | Superior Laryngeal Nerve Block | Neurogenic CoughUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
AllerganTerminatedUrinary Incontinence | Urinary Bladder | OveractiveUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaboratorsCompletedSuperficial Bladder CancerUnited States, Australia, New Zealand, Canada, United Kingdom
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
Telormedix SACompletedCarcinoma in Situ | Non Muscle Invasive Bladder CancerUnited States
-
Vaxiion TherapeuticsCompletedUrothelial Carcinoma of the Urinary BladderUnited States
-
NanOlogy, LLCUS Biotest, Inc.CompletedUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary BladderUnited States
-
Medical University of South CarolinaTerminated
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
Christopher Sweeney, MBBSEli Lilly and Company; Genentech, Inc.; Hoosier Cancer Research Network; Walther...CompletedBladder CancerUnited States
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
Trans Tasman Radiation Oncology GroupCompletedBladder CancerAustralia, New Zealand
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaActive, not recruitingBladder CancerAustralia
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingBladder Cancer | NMIBC | Urothelial Carcinoma Recurrent | Non-Muscle Invasive Bladder CancerUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Institute of Cancer Research, United KingdomTrans Tasman Radiation Oncology GroupActive, not recruitingBladder CancerUnited Kingdom, New Zealand, Australia
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Predictive BiosciencesCompletedBladder Cancer RecurrenceUnited States